Understanding the Science Behind Bile Supplements

Why These Ingredients. Why This Design.

Every ingredient in Gallavance was selected for a specific physiological role in bile-dependent fat digestion. This page explains the formulation logic behind the Gallavance system.

Formulation Design Principles

  • Why ox bile extract: Provides conjugated bile acids structurally similar to human bile, directly supplementing the bile pool that is reduced or desynchronized after gallbladder removal.
  • Why phosphatidylcholine (sunflower-derived): Comprises 90–95% of bile phospholipids. Selected from sunflower sources to avoid soy allergen concerns while maintaining functional equivalence.
  • Why delayed-release (DRcaps®): Bile acids work in the small intestine, not the stomach. Standard capsules release prematurely in gastric acid. DRcaps® technology resists stomach acid to deliver contents where fat emulsification occurs.
  • Why botanical support (artichoke, dandelion, ginger): Selected for their documented roles in supporting bile flow, digestive motility, and gastric comfort—complementing the primary bile and phospholipid components.

Science Library — Deep-Dive Pages

Explore individual ingredient research and delivery science:

Selected References

The following published studies and reviews informed the formulation logic and delivery design described on this page. Gallavance does not claim to replicate the outcomes of any individual study.

Bile Acid Physiology & Enterohepatic Circulation

  • Hofmann AF, Hagey LR. "Chemistry and enterohepatic circulation of bile acids." Hepatology. 2009. PMID: 19273221
  • Sips FLP et al. "Dynamics of the enterohepatic circulation of bile acids in healthy humans." Am J Physiol Gastrointest Liver Physiol. 2021;321(1):G55-G66. PMID: 33978477
  • Li T, Chiang JYL. "Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids." Acta Pharm Sin B. 2015. PMC: PMC4629214

Bile Acids & Fat Emulsification

  • Darkoh C et al. "Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles." Front Pharmacol. 2018;9:1283. PMC: PMC6233864
  • Bauer E et al. "On the role of bile salts in the digestion of emulsified lipids." Food Hydrocolloids. 2016;60:76-87. DOI: 10.1016/j.foodhyd.2016.03.016

Ox Bile Extract in Steatorrhea

  • Gruy-Kapral C et al. "Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon." Dig Dis Sci. 1992;37(6):929-933. PMID: 1587199

Phosphatidylcholine in Bile

  • Strandvik B et al. "Fatty acid composition of phospholipids in bile in man." Eur J Clin Invest. 1988;18(5):487-491. PMID: 3111757 — Confirmed that 95% of bile phospholipids are secreted as phosphatidylcholine.
  • Stahl E et al. "Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis." Lipids Health Dis. 2013;12:126. PMC: PMC3761098

Delayed-Release Capsule Technology (DRcaps®)

  • Capsugel. "Scintigraphic In Vivo Study of DRcaps Capsules." 2013. — Human clinical study confirming acid-resistant and delayed-release performance; mean release at 52 minutes post-ingestion. Source
  • Garbacz G et al. "Comparison of protection and release behavior of different capsule types." Int J Pharm. 2021;608:121082. DOI: 10.1016/j.ijpharm.2021.121082

GLP-1 Medications & Gastric Emptying

  • Jalleh RJ et al. "Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide." J Clin Endocrinol Metab. 2025;110(1):1-14. DOI: 10.1210/clinem/dgae764
  • Gu S et al. "Quantified metrics of gastric emptying delay by GLP-1 agonists: a systematic review and meta-analysis." J Clin Med. 2024. PMC: PMC11150091

This reference list is not exhaustive. Additional citations are provided on individual ingredient deep-dive pages linked above. All references are provided for educational context and do not imply that Gallavance replicates or achieves the specific outcomes described in any study.

This page provides an educational overview of bile physiology,
fat emulsification, and the delivery system design behind
Gallavance™ formulations.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.